Full text is available at the source.
Abstract
DNA ACE-tRNA vectors as small as 200 base pairs effectively suppress several nonsense mutations in CFTR and REP1.
- Nonsense mutations account for approximately 11% of all genetic lesions causing disease.
- Delivery methods for ACE-tRNAs include adeno-associated viral vectors and RNA-lipid nanoparticles, but these have notable drawbacks.
- DNA delivery methods are highlighted for their cost-effectiveness, durability, and safety compared to viral or RNA-based approaches.
- Linear DNA ACE-tRNA minivectors show significantly improved bioavailability and reduced immune response in cell and ex vivo models.
- These minivectors maintain superior biostability compared to traditional plasmid DNA vectors.
Simplified